Pilgrim Secures $3.25 Million Funding From Thiel Capital Cantos And Refactor

Pilgrim, a biotech startup founded by Thiel Fellow Jake Adler, is pioneering nanotechnology, bioelectronics, and AI-driven solutions to enhance military resilience and anti-threat biosurveillance. The company recently secured $3.25 million in funding from Thiel Capital, Cantos, and Refactor to advance its "Voyager" biotech platform, which includes nanoparticle-enabled vaccines and bio-hybrid wound-healing adhesives. Pilgrim aims to rapidly deploy innovative biotech for defense applications, with potential dual-use in civilian medicine, leveraging fast-track DoD-FDA approval pathways to accelerate development. FOUNDER: Thiel Fellow Jake Adler INVESTORS: Thiel Capital, Cantos, Refactor, Joshua Browder & Cory Levy AMOUNT: $3,250,000 HQ: #RedwoodCity #California #VentureCapital #Pilgrim #ThielCapital #Cantos #Refactor #ThielFellowJakeAdler #JoshuaBrowder #CoryLevy #TradedVC